X0306 4 2021-03-22 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2021-03-22 4 M 0 1199 20.93 A 1199 D Common Stock 2021-03-22 4 S 0 255 142.83 D 944 D Common Stock 2021-03-22 4 S 0 366 144.06 D 578 D Common Stock 2021-03-22 4 S 0 227 145.47 D 351 D Common Stock 2021-03-22 4 S 0 290 146.46 D 61 D Common Stock 2021-03-22 4 S 0 61 147.50 D 0 D Stock Option (Right to Buy) 20.93 2021-03-22 4 M 0 1199 0 D 2029-03-08 Common Stock 1199 169599 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.23 to $143.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.63 to $144.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.89 to $145.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.15 to $146.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Brian Sandstrom, as Attorney-in-Fact 2021-03-23